PubRank

Craig Meyers

Author PubWeight™ 59.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008 4.24
2 Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010 2.19
3 Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 2009 1.60
4 Propagation, infection, and neutralization of authentic HPV16 virus. Virology 2004 1.32
5 In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degeneration. Mol Ther 2010 1.26
6 Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS One 2011 1.26
7 microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 2014 1.25
8 Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther 2012 1.24
9 The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol 2007 1.22
10 Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol 2008 1.20
11 Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol 2009 1.18
12 Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev 2009 1.18
13 Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol Ther 2008 1.17
14 Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog 2013 1.15
15 Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 2011 1.11
16 Human papillomavirus type 45 propagation, infection, and neutralization. Virology 2003 1.09
17 Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal Biochem 2002 1.03
18 Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer 2011 1.01
19 Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology 2009 1.01
20 Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 2004 0.98
21 Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol Med 2005 0.98
22 Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter. J Virol 2005 0.95
23 Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line. J Virol 2006 0.93
24 Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species. Cancer Epidemiol Biomarkers Prev 2009 0.93
25 Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prev Res (Phila) 2010 0.93
26 The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 2005 0.92
27 Development of a microarray chip for gene expression in rabbit ocular research. Mol Vis 2007 0.92
28 Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol 2008 0.92
29 Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS One 2013 0.91
30 The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol 2011 0.90
31 Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol 2002 0.90
32 Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes. PLoS One 2011 0.90
33 Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS One 2011 0.90
34 Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol 2004 0.88
35 Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter. PLoS One 2011 0.87
36 α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Mol Ther 2010 0.86
37 Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology 2003 0.85
38 Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology. Neurobiol Learn Mem 2011 0.84
39 The roles of social domains, behavioral risk, health care resources, and chlamydia in spatial clusters of US cervical cancer mortality: not all the clusters are the same. Cancer Causes Control 2010 0.83
40 Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium. Antivir Ther 2010 0.83
41 Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes. J Virol 2009 0.82
42 Native human papillomavirus production, quantification, and infectivity analysis. Methods Mol Biol 2015 0.81
43 Papillomavirus capsid proteins mutually impact structure. Virology 2011 0.81
44 Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene. J Virol 2010 0.81
45 Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway. J Virol 2011 0.81
46 The adeno-associated virus major regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity. Virology 2003 0.80
47 Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells. Mol Cancer 2011 0.80
48 The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J Virol 2002 0.79
49 Simultaneously sensitive detection of multiple miRNAs based on a strand displacement amplification. Chem Commun (Camb) 2012 0.79
50 Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C. Virology 2006 0.79
51 Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium. Anticancer Res 2005 0.78
52 Study of infectious virus production from HPV18/16 capsid chimeras. Virology 2010 0.78
53 A risk for non-sexual transmission of human papillomavirus? Expert Rev Anti Infect Ther 2014 0.78
54 Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent. J Virol 2003 0.77
55 Analysis of HPV transcription by RPA. Methods Mol Med 2005 0.77
56 Comparative metabolism of benzo[a]pyrene by human keratinocytes infected with high-risk human papillomavirus types 16 and 18 as episomal or integrated genomes. J Carcinog 2012 0.76
57 Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus. Virus Res 2011 0.76
58 Replication of human papillomavirus in culture. Methods Mol Biol 2015 0.76
59 A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes. Mol Ther 2006 0.75
60 Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication. Anticancer Res 2005 0.75
61 Organotypic (raft) culture of biopsy-derived upper respiratory epithelium. Laryngoscope 2006 0.75